Crash,
Thanks so much for sharing.
On the EBITA, that's even better news than I'd thought. I'd forgotten that Stonepeaks share is based on an IRR calculation over EBITDA. As you say, this actually means an increase in to EBITA of the project has a multiplier effect on LNG EBITA for the project since we get an increased share of an increased total.
I had thought I'd understood correctly that MB was talking about the race being in relation to financial close. Even if BH comes close to Magnolia that puts FC for BH at, I believe, 6-12 months earlier than has been suggested so far.
On the MLP, this aligns with what I'd started to believe was the main hinted intention for some time. I won't bother boring everyone though and going back over the general concept of what I suspect they are intending. As for the listing here being for some time, there is no reason they couldn't mean it'll take some time for anything to happen, they could mean that the first step might be to switch from and ASX + ADR listing to a CDI + US listing arrangement (at least initially, before a US only listing).
- Forums
- ASX - By Stock
- LNG
- Ann: Shareholder Presentation
Ann: Shareholder Presentation, page-60
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LNG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online